ArticleArchives of microbiology2025
Dihydroartemisinin modulates the host proteome to suppress bovine viral diarrhea virus via mitochondrial and ER stress.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- BVDV utilizes PGC-1α downregulation to remodel the mitochondrial metabolic microenvironment, enhancing viral replication and impairing host immunity.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bovine Viral Diarrhea Virus (BVDV) remains a pervasive threat to cattle health and food security, yet the host pathways it exploits are only partially understood. Here, we employed high-resolution Orbitrap Astral FAIMS-DIA proteomics to interrogate Madin-Darby bovine kidney cells in three states: uninfected control (CON), BVDV-infected (CP), and BVDV-infected cells treated with dihydroartemisinin (DHA; CP_D). Quantification of more than 7,000 proteins revealed a conserved 98% core proteome, but sharply divergent condition-specific signatures. Infection alone upregulated complement coagulation and cytokine-receptor pathways, highlighting innate immune activation alongside zinc finger-rich transcriptional remodeling. DHA superimposed a distinct proteomic landscape, roughly doubling the number of differentially abundant proteins in the cytoplasm, mitochondria, and extracellular space, and markedly increasing the number of nuclear proteins. Enrichment analyses revealed a significant shift toward extracellular matrix receptor interactions, hematopoietic cell lineages, and kinase-dominated signaling. At the same time, network centrality identified newly emergent hubs within the protein kinase and immunoglobulin superfamilies. Domain-level evidence, combined with expanded metabolic pathway coverage, suggests that DHA orchestrates the parallel rewiring of signal transduction, matrix architecture, and bioenergetics, rather than merely reversing viral perturbations. Principal component clustering and hierarchical correlations confirmed that CP_D forms a reproducible proteomic state distinct from both CON and CP, arguing for a multimodal host reprogramming mechanism. Collectively, these data position DHA as a host-directed antiviral that partitions the proteome into defensive, signaling, and structural modules, offering a blueprint for multi-target intervention against pestiviral disease.
Indexed as
Identifiers
41081929What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.